- Home
- THR vs APLT Comparison
THR vs APLT Comparison
Compare THR & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THR
- APLT
- Stock Information
- Founded
- THR 1954
- APLT 2016
- Country
- THR United States
- APLT United States
- Employees
- THR N/A
- APLT N/A
- Industry
- THR Industrial Machinery/Components
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- THR Energy
- APLT Health Care
- Exchange
- THR Nasdaq
- APLT Nasdaq
- Market Cap
- THR 960.7M
- APLT 971.6M
- IPO Year
- THR 2011
- APLT 2019
- Fundamental
- Price
- THR $31.19
- APLT $9.27
- Analyst Decision
- THR Strong Buy
- APLT Strong Buy
- Analyst Count
- THR 1
- APLT 5
- Target Price
- THR $38.00
- APLT $12.50
- AVG Volume (30 Days)
- THR 222.1K
- APLT 1.7M
- Earning Date
- THR 11-07-2024
- APLT 11-07-2024
- Dividend Yield
- THR N/A
- APLT N/A
- EPS Growth
- THR 4.78
- APLT N/A
- EPS
- THR 1.29
- APLT N/A
- Revenue
- THR $493,855,000.00
- APLT N/A
- Revenue This Year
- THR $7.99
- APLT N/A
- Revenue Next Year
- THR $7.58
- APLT $3,169.03
- P/E Ratio
- THR $24.24
- APLT N/A
- Revenue Growth
- THR 3.94
- APLT N/A
- 52 Week Low
- THR $23.76
- APLT $1.79
- 52 Week High
- THR $35.93
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- THR 68.30
- APLT 54.08
- Support Level
- THR $29.79
- APLT $8.51
- Resistance Level
- THR $30.96
- APLT $9.86
- Average True Range (ATR)
- THR 1.22
- APLT 0.62
- MACD
- THR 0.35
- APLT -0.10
- Stochastic Oscillator
- THR 93.62
- APLT 35.95
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.